We recently confirmed Eif4g2 as a critical target of miR-139 in mouse MLL-AF9 AML [38], suggesting that Eif4g2 is a more common miR-139 target in leukemia. This evidence concerns the gene EIF4G2 and acute myeloid leukemia.